N-[4-[3-fluoro-4-(2-piperidin-4-ylethyl)phenoxy]-3-(2-methyl-1-oxoisoquinolin-4-yl)phenyl]ethanesulfonamide
C31H34FN3O4S — CID 171082123
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[3-fluoro-4-(2-piperidin-4-ylethyl)phenoxy]-3-(2-methyl-1-oxoisoquinolin-4-yl)phenyl]ethanesulfonamide
N-[4-[3-fluoro-4-(2-piperidin-4-ylethyl)phenoxy]-3-(2-methyl-1-oxoisoquinolin-4-yl)phenyl]ethanesulfonamide (PubChem CID 171082123) has the molecular formula C31H34FN3O4S and a molecular weight of 563.70 g/mol. Its IUPAC name is N-[4-[3-fluoro-4-(2-piperidin-4-ylethyl)phenoxy]-3-(2-methyl-1-oxoisoquinolin-4-yl)phenyl]ethanesulfonamide.
Molecular Properties
| Compound Name | N-[4-[3-fluoro-4-(2-piperidin-4-ylethyl)phenoxy]-3-(2-methyl-1-oxoisoquinolin-4-yl)phenyl]ethanesulfonamide |
|---|---|
| PubChem CID | 171082123 |
| Molecular Formula | C31H34FN3O4S |
| Molecular Weight | 563.70 g/mol |
| Exact Mass | 563.23 |
| IUPAC Name | N-[4-[3-fluoro-4-(2-piperidin-4-ylethyl)phenoxy]-3-(2-methyl-1-oxoisoquinolin-4-yl)phenyl]ethanesulfonamide |
| SMILES | CCS(=O)(=O)Nc1ccc(Oc2ccc(CCC3CCNCC3)c(F)c2)c(-c2cn(C)c(=O)c3ccccc23)c1 |
| InChI | InChI=1S/C31H34FN3O4S/c1-3-40(37,38)34-23-11-13-30(27(18-23)28-20-35(2)31(36)26-7-5-4-6-25(26)28)39-24-12-10-22(29(32)19-24)9-8-21-14-16-33-17-15-21/h4-7,10-13,18-21,33-34H,3,8-9,14-17H2,1-2H3 |
| InChIKey | AIKCSKNDORTODH-UHFFFAOYSA-N |
| XLogP | 5.83 |
| TPSA | 89.43 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 563.70 |
| LogP ≤ 5 | 5.83 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171082123 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.